Goldman Sachs
ZURA icon

Goldman Sachs’s Zura Bio ZURA Stock Holding History

Goldman Sachs’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.39M Buy
573,946
+421,031
+275% +$2.01M ﹤0.01% 4244
2026
Q1 		$910K Sell
152,915
-63,895
-29% -$386K ﹤0.01% 5157
2025
Q4 		$1.14M Buy
216,810
+135,087
+165% +$534K ﹤0.01% 5049
2025
Q3 		$354K Sell
81,723
-220,968
-73% -$397K ﹤0.01% 5685
2025
Q2 		$318K Buy
302,691
+179,715
+146% +$215K ﹤0.01% 5407
2025
Q1 		$159K Sell
122,976
-21,107
-15% -$33.3K ﹤0.01% 5681
2024
Q4 		$360K Buy
144,083
+46,709
+48% +$166K ﹤0.01% 5415
2024
Q3 		$395K Buy
+97,374
New +$364K ﹤0.01% 5178
2024
Q1 		– Sell
-19,458
Closed -$90.9K – 5931
2023
Q4 		$90.9K Buy
19,458
+2,002
+11% +$10K ﹤0.01% 5308
2023
Q3 		$115K Buy
+17,456
New +$117K ﹤0.01% 5158

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs's ZURA Position: Q2 2026 in Review

Goldman Sachs increased its Zura Bio (ZURA) stake by 275% in Q2 2026, buying an estimated $2.01M and bringing the position to 573,946 shares worth $3.39M. The position accounts for ﹤0.01% of the portfolio, ranked #4244.

Goldman Sachs first reported a position in ZURA in Q3 2023 and has held it in 10 quarters since. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Goldman Sachs held 573,946 shares of Zura Bio worth $3.39M as of Q2 2026.
  • Goldman Sachs bought 421,031 Zura Bio shares in Q2 2026, an estimated $2.01M.
  • Zura Bio made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4244 holding.
  • Goldman Sachs first reported a position in Zura Bio in Q3 2023 and has held it in 10 quarters since.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.